Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
close-panel

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Get Notifications

Sign up to receive email updates from Charlotte Lozier Institute.

Become A Defender of Life

Your donation helps us continue to provide world-class research in defense of life.

DONATE

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Research Type: Articles

Filter Results By

Filter Applied. Clear All

Latest Posts

April 10, 2024 New Study: Abortion Increases Risk of Cardiovascular Diseases New Study: Abortion Increases Risk of Cardiovascular Diseases April 2, 2024 Abortion Reporting: Florida (2023) Abortion Reporting: Florida (2023) March 25, 2024 Filed: CLI Amicus Brief in Idaho’s Moyle v. United States EMTALA Case Filed: CLI Amicus Brief in Idaho’s Moyle v. United States EMTALA Case
Reset All Filters
Maternal & Public Health

CLI Authors’ Responses to Sage Concerns and Retractions

On February 5, 2024, Sage Publications retracted three peer-reviewed articles authored by affiliates of the Charlotte Lozier Institute. Prior to these retractions, Sage issued an expression of concern against the first of the three articles in July of 2023. Reproduced here are the authors’ initial response to Sage’s notice informing CLI of its intention to issue an expression of concern, as well as the authors’ subsequent response to the official retractions.

CLI Scholars React to Nature Medicine Study
Chemical Abortion

CLI Scholars React to Nature Medicine Study

Following the release of a study in Nature Medicine, which discussed the “safety and effectiveness” of abortion drugs acquired through telehealth, Tessa Longbons Cox, senior research associate at the Charlotte Lozier Institute, made the following statement:

Charlotte Lozier Institute Responses to Sage Retractions
General

Charlotte Lozier Institute Responses to Sage Retractions

The Charlotte Lozier Institute (CLI) and associate scholars are facing an unprecedented attack on our research. We believe that because our research has been widely read and cited, including in prominent legal contexts, we are now subject to unprovoked and partisan assault. Sage Publishing, an academic publishing company, retracted three of our studies on February 5, 2024. This action is meritless because, among other things, Sage to this day has advanced no legitimate objection to any findings of the studies.

Maternal & Public Health

Abortion Reporting: Pennsylvania (2022)

Pennsylvania’s 2022 abortion report was published online by the Pennsylvania Department of Health in December 2023. The report shows that abortions increased from the previous year.

Maternal & Public Health

Abortion Reporting: Idaho (2022)

The Idaho Department of Health and Welfare released their annual vital statistics report, showing that abortions declined in 2022 from the previous year.

Maternal & Public Health

Abortion Reporting: Arizona (2022)

Arizona’s 2022 abortion report was published online by the Arizona Department of Health Services in December 2023.

Fetal Tissue, Stem Cells & Bioethics

Stopping the Pain and Saving Lives: Successful Treatments for Sickle Cell Disease

The U.S. Food and Drug Administration (FDA) recently approved not just one, but two new gene therapies for sickle cell disease. The success of adult stem cell therapies continues to demonstrate that the progress of science and medicine need not rely on ethically compromised research and treatment approaches.

Chemical Abortion

Chemical Abortion Explainer

It is a scientific fact that the embryo or fetus within the mother’s womb is a distinct human being, and, consequently, abortion ends the life of that human being.

Become A Defender of Life

Your donation helps us continue to provide
world-class research in defense of life.

BECOME A PARTNER
cta-image